The aim of this study was to investigate the reliability of disc diffusion testing with penicillin, erythromycin and ciprofloxacin within the viridans group streptococci (VGS). In total, the antibiotic susceptibilities of 167 VGS isolates were compared by standard disc diffusion and broth microdilution methods, and these phenotypic data were compared to the carriage of the respective gene resistance determinants [ermB and mefA/E (macrolides); QRDR, gyrA, gyrB, parC and parE (quinolones)]. Overall, there were 35 discrepancies [resistant by MIC and susceptible by zone diameter (21.0 %)] between MIC and disc diameter when penicillin susceptibility was interpreted by Clinical and Laboratory Standards Institute criteria. Scattergrams showed a bimodal distribution between non-susceptible and susceptible strains when erythromycin susceptibility was tested by both methods. Thirty-four (20.4 %) isolates were categorized as resistant by MIC breakpoints, while disc diameter defined these as having intermediate resistance. With ciprofloxacin, three isolates (1.8 %) showed minor discrepancies between MIC breakpoints and disc diameter. Isolates nonsusceptible to all three antimicrobial agents tested were reliably distinguished from susceptible isolates by disc diffusion testing, except for the detection of low-level resistance to penicillin, where broth microdilution or an alternative quantitative MIC method should be used. Otherwise, we conclude that disc diffusion testing is a reliable method to detect strains of VGS non-susceptible to penicillin, erythromycin and ciprofloxacin, as demonstrated with their concordance to their gene resistance characteristics.
INTRODUCTION
Viridans group streptococci (VGS) are causative agents of infective endocarditis (IE) and bacteraemia (Razonable et al., 2002) . In neutropenic patients and cancer patients, VGS cause viridans-related septic shock syndrome, which results in high mortality (40-100 %) (Bruckner & Gigliotti, 2006) . The emergence of antimicrobial-resistant VGS has been reported worldwide, although the resistant rates are variable due to differences in the sampling targets in each study. Resistance rates are as follows: penicillin resistance rate ranges from 2.3 to 58.0 % (Finland, Korea), erythromycin resistance rate ranges from 17.0 to 79.3 % (Sweden, Spain) and quinolone resistance rate ranges from 2.6 to 72.0 % (UK, USA) (Lindgren et al., 2007; Uh et al., 2004; Westling et al., 2006; Cerdá Zolezzi et al., 2004; Kerr et al., 1999; Han et al., 2006) .
To determine antimicrobial susceptibility, disc diffusion and broth microdilution methods are widely employed. In particular, the standardized disc diffusion test is the most frequently used methodology in the clinical microbiology laboratory, because of its relatively low cost and its wide application in most clinical microbiology analyses globally. The American Proficiency Institute and the World Health Organization have reported a wide diversity in results from laboratories that use disc diffusion testing to determine susceptibilities of Streptococcus pneumoniae (Tenover et al., 2001; Edson et al., 2006) . Therefore, it is important to have reliable interpretive standards for disc diffusion testing with VGS organisms, as well as MIC breakpoints. Currently, such criteria for VGS are incomplete relating to Clinical and Laboratory Standards Institute (CLSI) standard methodology, for example, penicillin disc diffusion testing is commented on as not being reliable and ciprofloxacin is not included in the interpretive standards (CLSI, 2005) . In this study, we wished to evaluate the CLSI criteria for erythromycin, and to look into the possibility of developing interpretive criteria for susceptibility testing for penicillin and ciprofloxacin with VGS organisms.
METHODS
Bacterial isolates. VGS (n5167), were obtained from the culture collection of the Northern Ireland Public Health Laboratory, Belfast City Hospital. These isolates had originally been collected from respiratory specimens, and had been obtained by conventional microbiological culture techniques for the presence of VGS organisms and pneumococci. All isolates were recovered on Columbia Blood agar (Oxoid) supplemented with 5 % (v/v) defibrinated horse blood and incubated for 24 h at 37 uC, under microaerophilic conditions, with 5 % (v/v) CO 2 . The identity of each VGS isolate employed in this study was determined molecularly by the sequencing of five gene loci, namely rnpB, 16S rRNA, 16S-23S rRNA, sodA and dnaJ (unpublished data). Characteristics of macrolide resistance determinant genes and quinolone resistance-determining regions (QRDRs) are summarized in Tables 1 and 2 .
Determination of antimicrobial susceptibility. Antibiotic susceptibility tests for penicillin, erythromycin and ciprofloxacin were performed on all VGS isolates and pneumococci by standard disc susceptibility analysis, as well as by determination of the MIC value. Standardized routine disc susceptibility tests were performed employing an inoculum density of each isolate at a McFarland 0.5 standard. The MIC for the same antibiotics was determined by broth microdilution according to the CLSI standard method (CLSI, 2005) . Susceptibility was interpreted using the criteria for 'Streptococcus spp. other than Streptococcus pneumoniae'. In order to estimate ciprofloxacin susceptibility, interpretive criteria for ofloxacin were used. Susceptibility test discs and lyophilized antimicrobial tablets were purchased from Becton Dickinson and MAST, respectively.
Molecular characterization of macrolide-and fluoroquinoloneresistance determinants. The QRDRs, gyrA, gyrB, parC and parE gene loci, were analysed through sequence typing for all VGS isolates examined (Maeda et al., 2011) , as well as carrying out detection and characterization of the macrolide resistance determinants, the ermB and mefA/E gene loci (Tazumi et al., 2009) . These methods employed the sequencing of known gene resistance determinants associated with macrolide resistance, as well as fluoroquinolone resistance.
RESULTS
The MICs from broth microdilution tests and zone diameters of disc diffusion tests are shown in Tables 1 and 2 . Overall, there were 35 major discrepancies [i.e. resistant by MIC and susceptible by zone diameter (NCCLS, 1994) (21.0 %)] between MIC and disc diameter when penicillin susceptibility was interpreted by CLSI criteria (Fig. 1a) . Scattergrams showed a bimodal distribution of organisms between non-susceptible and susceptible strains when erythromycin susceptibility was tested by both methods (Fig. 1b) . Thirty-four (20.4 %) isolates were categorized as resistant by MIC breakpoints, while disc diameter defined these as intermediate (minor discrepancies). With ciprofloxacin, three isolates (1.8 %) showed minor discrepancies, where two were resistant and intermediate by MIC breakpoints and disc diameter, and the reverse for the one remaining isolate (Fig. 1c) .
DISCUSSION
Taking the broth microdilution method as the gold standard, we demonstrated that 35 penicillin-resistant strains were incorrectly identified as penicillin susceptible by disc diffusion testing using 10 unit penicillin discs, which corroborates a previous statement from the CLSI regarding CLSI interpretive standards, that penicillin, ampicillin and oxacillin disc diffusion testing is not reliable with VGS organisms. Although resistant strains (MIC ¢1 mg ml 21 ) were correctly identified by disc diffusion testing, from our results, it appears to be necessary to employ MIC methods to detect the intermediate susceptibility/resistance of VGS organisms. The clinical microbiologist ought to be aware ; and susceptible, ¡0.12 mg ml
21
. In such cases, the full MIC should be determined rather than relying solely on disc diffusion testing.
In the case of erythromycin susceptibility testing, results obtained by disc testing were considered valid, as we could positively match these against molecular characterization of the ermB and mefA/E gene determinant loci. Those isolates that possessed the ermB gene, which confers highlevel macrolide resistance, were categorized as resistant, while all strains assigned as intermediate possessed the mefA/E gene, which confers low-level resistance. Furthermore, none of the susceptible strains harboured either of these genes. Therefore, disc diffusion testing could be used to detect erythromycin resistant and intermediate strains reliably.
Ciprofloxacin susceptibility was found to have the best concordance between disc diffusion and broth microdilution methods, even though ofloxacin interpretive standards were applied. Again, we were able to compare the phenotypic susceptibility data with the molecular QRDR characteristics of VGS organisms, which showed a good correlation between methods. None of the isolates having QRDR mutations were assigned as susceptible but were assigned as intermediate or resistant, whereas all other isolates with no QRDR mutation were categorized as susceptible, with a few exceptional isolates resistant via an active efflux pump. This mechanism confers low-level resistance and the feature is inhibited by reserpine. On account of this feature, it is easily monitored during MIC tests. Jumbe et al. (2006) have suggested that active efflux pumps play a key role during the development of fluoroquinolone resistance. The low-level resistance caused by efflux pumps can increase the number of opportunities to obtain target mutations. Although it used to be considered that there was only one efflux system for fluoroquinolone resistance, putative ATPdependent efflux proteins PatA and PatB were described recently. The difference of this efflux system and the PmrA efflux system is its sensitivity to reserpine. PatA and PatB efflux systems are not influenced by reserpine (Marrer et al., 2006) . These results suggest that interpreting ciprofloxacin disc diameter with ofloxacin criteria can detect ciprofloxacin non-susceptible isolates, and potentially distinguish resistant and intermediate isolates. The ability to detect low-level resistance is important, as this can be caused by first step mutations in the QRDR, which will elevate the potential of the development of double mutations conferring high-level resistance (Schurek et al., 2006) .
In conclusion, isolates non-susceptible to all three antimicrobial agents tested were reliably distinguished from susceptible isolates by disc diffusion testing, except for the detection of low-level resistance to penicillin, where broth microdilution or an alternative quantitative MIC method should be used. Otherwise, we conclude that disc diffusion testing is a reliable method to detect strains of VGS non-susceptible to penicillin, erythromycin and ciprofloxacin. 
